alveron.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
User-agent: * Allow: / # Optimization for Google Ads Bot User-agent: AdsBot-Google-Mobile User-agent: AdsBot-Google Disallow: /_api/* Disallow: /_partials* Disallow: /pro-gallery-webapp/v1/galleries/* # Block PetalBot User-agent: PetalBot Disallow: / Sitemap: https://www.alveron.com/sitemap.xml # Auto generated, go to SEO Tools > Robots.txt Editor to change | ||
Meta Tags
| Title | HOME | Alveron |
| Description | Alveron’s drug OKL-1111 is a potential break-through in the treatment of haemorrhagic stroke, a Alveron Pharma is developing a unique coagulation platform technology with the world’s first cyclodextrin-based anticoagulant reversal |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 23.236.62.147 |
| Location | United States |
Related Websites
| Site | Rank |
More to Explore
alveron.com Valuation
|
US$1,260,044
Last updated: 2023-05-17 03:09:27
alveron.com has Semrush global rank of 8,399,948. alveron.com has an estimated worth of US$ 1,260,044, based on its estimated Ads revenue. alveron.com receives approximately 145,390 unique visitors each day. Its web server is located in United States, with IP address 23.236.62.147. According to SiteAdvisor, alveron.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$1,260,044 |
| Daily Ads Revenue | US$1,164 |
| Monthly Ads Revenue | US$34,894 |
| Yearly Ads Revenue | US$418,723 |
| Daily Unique Visitors | 9,693 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| alveron.com. | A | 3595 | IP: 23.236.62.147 |
| alveron.com. | NS | 3600 | NS Record: ns1.webhostingserver.nl. |
| alveron.com. | NS | 3600 | NS Record: ns2.webhostingserver.nl. |
| alveron.com. | NS | 3600 | NS Record: ns3.webhostingserver.nl. |
| alveron.com. | MX | 3600 | MX Record: 10 alveron-com.mail.protection.outlook.com. |
| alveron.com. | TXT | 3600 | TXT Record: v=spf1 include:spf.protection.outlook.com -all |
| alveron.com. | TXT | 3600 | TXT Record: MS=ms75809400 |
HtmlToTextCheckTime:2023-05-17 03:09:27
| top of page HOME COMPANY HISTORY TEAM SUPERVISORY BOARD SCIENTIFIC ADVISORY BOARD INVESTORS TECHNOLOGY CONTACT NEWS Alveron’s drug OKL-1111 is a potential break-through in the treatment of haemorrhagic stroke, a severe unmet medical need. LATEST NEWS Alveron Pharma starts the first clinical trial of new drug for treatment of intracranial haemorrhage Contact Haemorrhagic stroke or intracranial haemorrhage (ICH) is a devastating condition with a 30-50% mortality rate. ICH is also responsible for approximately 50% of disability associated with stroke as a whole. The use of anticoagulants or platelet inhibitors greatly increases the probability and severity of ICH. One of the major reasons for these poor outcomes is that patients are simply treated too late with reversal agents. Current therapies require the identity of the anticoagulant; consultation with an expert; dose calculations with some requiring patient weight and reconstitution of multiple vials of powder into solution. This |
alveron.com Whois Information
Domain Name: ALVERON.COM Registry Domain ID: 1810385624_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.registrar.eu Registrar URL: http://www.openprovider.com Updated Date: 2022-03-01T12:27:33Z Creation Date: 2013-06-23T18:45:31Z Registry Expiry Date: 2024-06-23T18:45:31Z Registrar: Hosting Concepts B.V. d/b/a Registrar.eu Registrar IANA ID: 1647 Registrar Abuse Contact Email: abuse@registrar.eu Registrar Abuse Contact Phone: +31.104482297 Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Name Server: NS1.WEBHOSTINGSERVER.NL Name Server: NS2.WEBHOSTINGSERVER.NL Name Server: NS3.WEBHOSTINGSERVER.NL DNSSEC: signedDelegation DNSSEC DS Data: 27436 13 2 3FA29369552AEB06F537E562B61E2E9AF764DB27C8013D4447553D62E5530154 >>> Last update of whois database: 2022-03-02T10:35:28Z <<< |